SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification sought from Sanofi India

11 Dec 2015 Evaluate

The Exchange has sought clarification from Sanofi India on December 11, 2015 with reference to news reported in Business Standard on December 11, 2015- ‘Sanofi Pasteur in talks to bring first dengue vaccine to India’.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3270.00 -57.85 (-1.74%)
11-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×